AF
AXNX

Amalgamated Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

Amalgamated Financial’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$470K Buy
+7,502
New +$404K ﹤0.01% 1546

Other funds holding AXNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Amalgamated Financial's AXNX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Axonics, Inc. Common Stock (AXNX) in Q1 2022: 7,502 shares worth $470K. The stake represents ﹤0.01% of the portfolio and ranks #1546 among its holdings.

186 funds tracked by Wall St. Rank hold AXNX as of Q1 2022.

  • Amalgamated Financial held 7,502 shares of Axonics, Inc. Common Stock worth $470K as of Q1 2022.
  • Axonics, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • Axonics, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1546 holding.
  • 186 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.